» Articles » PMID: 20151996

A Low Carbohydrate Mediterranean Diet Improves Cardiovascular Risk Factors and Diabetes Control Among Overweight Patients with Type 2 Diabetes Mellitus: a 1-year Prospective Randomized Intervention Study

Overview
Specialty Endocrinology
Date 2010 Feb 16
PMID 20151996
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The appropriate dietary intervention for overweight persons with type 2 diabetes mellitus (DM2) is unclear. Trials comparing the effectiveness of diets are frequently limited by short follow-up times and high dropout rates.

Aim: The effects of a low carbohydrate Mediterranean (LCM), a traditional Mediterranean (TM), and the 2003 American Diabetic Association (ADA) diet were compared, on health parameters during a 12-month period.

Methods: In this 12-month trial, 259 overweight diabetic patients (mean age 55 years, mean body mass index 31.4 kg/m(2)) were randomly assigned to one of the three diets. The primary end-points were reduction of fasting plasma glucose, HbA1c and triglyceride (TG) levels.

Results: 194 patients out of 259 (74.9%) completed follow-up. After 12 months, the mean weight loss for all patients was 8.3 kg: 7.7 kg for ADA, 7.4 kg for TM and 10.1 kg for LCM diets. The reduction in HbA1c was significantly greater in the LCM diet than in the ADA diet (-2.0 and -1.6%, respectively, p < 0.022). HDL cholesterol increased (0.1 mmol/l +/- 0.02) only on the LCM (p < 0.002). The reduction in serum TG was greater in the LCM (-1.3 mmol/l) and TM (-1.5 mmol/l) than in the ADA (-0.7 mmol/l), p = 0.001.

Conclusions: An intensive 12-month dietary intervention in a community-based setting was effective in improving most modifiable cardiovascular risk factors in all the dietary groups. Only the LCM improved HDL levels and was superior to both the ADA and TM in improving glycaemic control.

Citing Articles

Impact of very low carbohydrate ketogenic diets on cardiovascular risk factors among patients with type 2 diabetes; GRADE-assessed systematic review and meta-analysis of clinical trials.

Ghasemi P, Jafari M, Jafari Maskouni S, Hosseini S, Amiri R, Hejazi J Nutr Metab (Lond). 2024; 21(1):50.

PMID: 39030553 PMC: 11264514. DOI: 10.1186/s12986-024-00824-w.


The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes.

Minari T, Manzano C, Tacito L, Yugar L, Sedenho-Prado L, de Azevedo Rubio T Nutrients. 2024; 16(9).

PMID: 38732624 PMC: 11085322. DOI: 10.3390/nu16091378.


Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes-The MoKaRi II Randomized Controlled Study.

Braun T, Drobner T, Kipp K, Kiehntopf M, Schlattmann P, Lorkowski S Nutrients. 2024; 16(9).

PMID: 38732508 PMC: 11085300. DOI: 10.3390/nu16091261.


The effects of Mediterranean diet on cardiovascular risk factors, glycemic control and weight loss in patients with type 2 diabetes: a meta-analysis.

Zheng X, Zhang W, Wan X, Lv X, Lin P, Si S BMC Nutr. 2024; 10(1):59.

PMID: 38641818 PMC: 11027355. DOI: 10.1186/s40795-024-00836-y.


Improvement in Visceral Adipose Tissue and LDL Cholesterol by High PUFA Intake: 1-Year Results of the NutriAct Trial.

Meyer N, Pohrt A, Wernicke C, Pletsch-Borba L, Apostolopoulou K, Haberbosch L Nutrients. 2024; 16(7).

PMID: 38613089 PMC: 11013849. DOI: 10.3390/nu16071057.